|
1
|
Jochum F, Angeles MA, Balaya V, Drouin L, Nikolova T, Mathevet P, Lécuru F, Azais H, Betrian S, Bolze PA, Dabi Y, Kerbage Y, Sanson C, Zaccarini F, Guyon F, Akladios C, Hsu A, Bendifallah S, Deluche E, Guani B. Management of patients with advanced epithelial ovarian cancer: a European survey. Arch Gynecol Obstet 2023; 308:535-549. [PMID: 36737552 DOI: 10.1007/s00404-023-06948-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/20/2022] [Accepted: 01/24/2023] [Indexed: 02/05/2023]
Abstract
BACKGROUND The aim of this study was to assess current European practices in the management of patients with advanced epithelial ovarian cancer in 2021. METHODS A 58-question electronic survey was distributed anonymously to the members of six European learned societies. Initial diagnostic workup and staging, pathological data, surgical data, treatments and follow-up strategies were assessed. RESULTS A total of 171 participants from 17 European countries responded to emailed surveys. Most participants were experienced practitioners (superior than 15 years of experience) specializing in gynecology-obstetrics (29.8%), surgical oncology (25.1%), and oncogynecology (21.6%). According to most (64.8%) participants, less than 50% of patients were eligible for primary debulking surgery. Variations in the rate of primary debulking surgery depending on the country of origin of the practitioners were observed in this study. The LION study criteria were applied in 70.4% of cases during PDS and 27.1% after chemotherapy. In cases of BRCA1-2 mutations, olaparib was given by 75.0-84.8% of respondents, whereas niraparib was given in cases of BRCA wild-type diseases. CONCLUSIONS This study sheds light on current practices and attitudes regarding the management of patients with advanced epithelial ovarian cancer in Europe in 2021.
Collapse
Affiliation(s)
- Floriane Jochum
- Department of Obstetrics and Gynecology, University Hospital, Strasbourg, France.
- Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, Paris, France.
| | - Martina Aida Angeles
- Department of Surgical Oncology, Institut Claudius Regaud, Institut Universitaire du Cancer de Toulouse (IUCT), Oncopole, Toulouse, France
| | - Vincent Balaya
- Department of Obstetrics and Gynecology, Foch Hospital, Suresnes, France
| | - Leonor Drouin
- Department of Gynecology, CHU de Limoges, Limoges, France
| | - Tanja Nikolova
- Academic Teaching Hospital of Heidelberg University, Baden-Baden, Germany
| | - Patrice Mathevet
- Women-Mother-Child Department, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland
| | - Fabrice Lécuru
- Breast, Gynecology and Reconstructive Surgery Unit, Curie Institute, Paris, France
| | - Henri Azais
- Gynecologic and Breast Oncologic Surgery Department, Georges Pompidou European Hospital, Paris, France
| | - Sarah Betrian
- Department of Medical Oncology, IUCT Oncopole, Toulouse, France
| | | | - Yohann Dabi
- Department of Gynecology, Tenon Hospital, AP-HP, Paris, France
| | - Yohan Kerbage
- Department of Gynecology, Jeanne de Flandre Hospital, Lille, France
| | - Claire Sanson
- Surgical Oncology Department, Gustave Roussy Institute, Villejuif, France
| | - François Zaccarini
- Surgical Oncology Department, Gustave Roussy Institute, Villejuif, France
| | - Fréderic Guyon
- Surgical Oncology Department, Bergonié Institute, Bordeaux, France
| | - Cherif Akladios
- Department of Obstetrics and Gynecology, University Hospital, Strasbourg, France
| | - Arthur Hsu
- Department of Obstetrics and Gynecology, National Taiwan University Hospital Hsin-Chu Branch, Hsinchu, Taiwan
| | | | - Elise Deluche
- Oncology Department, University Hospital, Limoges, France
| | - Benedetta Guani
- Department of Obstetrics and Gynecology, Fribourg Hospital, Fribourg, Switzerland
| |
Collapse
|
|
2
|
Gauci PA, Deluche E, Azais H, Zaccarini F, Guani B, Balaya V, Kerbage Y, Jochum F, Sanson C, Guyon F, Akladios C, Bendifallah S, Dabi Y. Surgical management of patients with advanced ovarian cancer: Results of a French National Survey. J Gynecol Obstet Hum Reprod 2022; 51:102463. [DOI: 10.1016/j.jogoh.2022.102463] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/28/2022] [Revised: 08/18/2022] [Accepted: 08/23/2022] [Indexed: 11/30/2022]
|